Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism(s): implications to manganese‐induced parkinsonism
暂无分享,去创建一个
L. Pham | T. Guilarte | J. Schneider | D. Wong | Yun Zhou | Michael E Griswold | J. McGlothan | T. Syversen | Neal C. Burton | T. Verina | M. Alexander | Michael E. Griswold
[1] James Robert Brašić,et al. VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease , 2008, Journal of neurochemistry.
[2] A. Stepens,et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. , 2008, The New England journal of medicine.
[3] Josephine A. Wright,et al. Alpha‐synuclein and its role in metal binding: Relevance to Parkinson's disease , 2008, Journal of neuroscience research.
[4] Roberto G Lucchini,et al. High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. , 2007, American journal of industrial medicine.
[5] J. Wiederkehr,et al. Liver transplantation in a patient with rapid onset parkinsonism-dementia complex induced by manganism secondary to liver failure. , 2007, Arquivos de neuro-psiquiatria.
[6] D. Perl,et al. The Neuropathology of Manganese-Induced Parkinsonism , 2007, Journal of neuropathology and experimental neurology.
[7] Michael Jerrett,et al. A study of the relationships between Parkinson's disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. , 2007, Environmental research.
[8] Yu Kyeong Kim,et al. Dopamine transporter SPECT of a liver cirrhotic with atypical parkinsonism. , 2007, Industrial health.
[9] Janneke Koerts,et al. Striatal dopaminergic activity (FDOPA‐PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease , 2007, The European journal of neuroscience.
[10] D. Surmeier,et al. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons , 2007, Trends in Neurosciences.
[11] Hasan Meral,et al. Parkinsonism Caused by Chronic Usage of Intravenous Potassium Permanganate , 2007, The neurologist.
[12] P. Cooney,et al. Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. , 2007, Environmental toxicology and pharmacology.
[13] G. Hanson,et al. New insights into the mechanism of action of amphetamines. , 2007, Annual review of pharmacology and toxicology.
[14] T. Guilarte,et al. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.
[15] T. Guilarte,et al. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[16] T. Guilarte,et al. Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates , 2006, Brain Research.
[17] Yun Zhou,et al. An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge , 2006, NeuroImage.
[18] Carlos Santos-Burgoa,et al. Motor alterations associated with exposure to manganese in the environment in Mexico. , 2006, The Science of the total environment.
[19] Xu-Feng Huang,et al. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia , 2006, Experimental Brain Research.
[20] W. Koller,et al. The diagnosis of manganese-induced parkinsonism. , 2006, Neurotoxicology.
[21] Dean F Wong,et al. Acute manganese administration alters dopamine transporter levels in the non-human primate striatum. , 2006, Neurotoxicology.
[22] Thomas C. Südhof,et al. α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.
[23] D. Jennings,et al. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders , 2005, Neurology.
[24] C. Olanow,et al. Manganese‐Induced Parkinsonism and Parkinson's Disease , 2004, Annals of the New York Academy of Sciences.
[25] T. Yen,et al. Dopamine transporter binding in chronic manganese intoxication , 2003, Journal of Neurology.
[26] Donna Mergler,et al. Manganese, monoamine metabolite levels at birth, and child psychomotor development. , 2003, Neurotoxicology.
[27] R. Moratalla,et al. Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia , 2003, Neuroscience.
[28] M. Kubota,et al. Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition , 2003, Pediatric Surgery International.
[29] C. Yoo,et al. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: What does it mean? , 2002, Movement disorders : official journal of the Movement Disorder Society.
[30] V. Uversky,et al. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.
[31] J. Texcalac-Sangrador,et al. Exposure to manganese: health effects on the general population, a pilot study in central Mexico. , 2001, Environmental research.
[32] J. Mink,et al. Welding-related parkinsonism , 2001, Neurology.
[33] A. Toga,et al. The Rhesus Monkey Brain in Stereotaxic Coordinates , 1999 .
[34] E. Montgomery,et al. Central nervous system toxicity of manganese. II: Cocaine or reserpine inhibit manganese concentration in the rat brain. , 1999, Neurotoxicology.
[35] D. Mash,et al. Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease , 1999, Experimental Neurology.
[36] T. Reader,et al. Distribution of dopamine transporters in basal ganglia of cerebellar ataxic mice by [125I]RTI-121 quantitative autoradiography , 1998, Neurochemistry International.
[37] B. Snow,et al. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication , 1997, Neurology.
[38] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[39] S. Gilman,et al. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging , 1996, Annals of neurology.
[40] R. Butterworth,et al. Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy , 1995, Metabolic Brain Disease.
[41] C. Martínez,et al. Manganese intoxication and chronic liver failure , 1994, Annals of Neurology.
[42] N. Chu,et al. Levodopa failure in chronic manganism , 1994, Neurology.
[43] Hiroshi Kita,et al. Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs , 1990, Brain Research.
[44] N. Chu,et al. Positron emission tomography in manganese intoxication , 1989, Annals of neurology.
[45] T. Guilarte,et al. Effects of Perinatal Vitamin B6 Deficiency on Dopaminergic Neurochemistry , 1987, Journal of neurochemistry.
[46] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[47] R Rahamimoff,et al. Neuromuscular Transmission: Inhibition by Manganese Ions , 1972, Science.
[48] Alan J. Taylor,et al. Changes in manganese and lead in the environment and young children associated with the introduction of methylcyclopentadienyl manganese tricarbonyl in gasoline--preliminary results. , 2006, Environmental research.
[49] R. Bell,et al. Effects of chronic alcohol and repeated deprivations on dopamine D1 and D2 receptor levels in the extended amygdala of inbred alcohol-preferring rats. , 2006, Alcoholism, clinical and experimental research.
[50] B. Långström,et al. Manganese induced brain lesions inMacaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging , 2005, Archives of Toxicology.
[51] T. Südhof,et al. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.
[52] H. Watanabe,et al. Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain , 2004, Acta Neuropathologica.
[53] J. Farrar,et al. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. , 2001, Neurology.
[54] S. Asenbaum,et al. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy. , 1997, Journal of neural transmission. Supplementum.